跳转到主要内容

嗜睡

嗜睡(也称困倦)在医学上被认定为一种近乎睡眠的状态,或是一种强烈的睡眠欲望,同时并不感到躯体能量水平下降。这种状态独立于昼夜节律;因此,与镇静不同,这种效应不一定会降低躯体能量水平,而是降低清醒度。它最常见于多种化合物的中度剂量作用下,例如大麻素类、GABA能抑制剂、阿片类、抗精神病药、部分第一代抗组胺药以及某些迷幻剂。

嗜睡(也称困倦)在医学上被认定为一种近乎睡眠的状态,或是一种强烈的睡眠欲望,同时并不感到躯体能量水平下降。123 这种状态独立于昼夜节律1;因此,与镇静不同,这种效应不一定会降低躯体能量水平,而是降低清醒度。它会导致疲倦、头脑昏沉和易入睡的行为倾向。这可能使完成任务的动力下降,因为睡眠欲望的增强开始压倒其他考虑。在不适当休息的情况下长期暴露于这种效应,可能导致认知疲劳以及一系列其他认知抑制。

嗜睡最常见于多种化合物的中度剂量作用下,例如大麻素类4、GABA能抑制剂56、阿片类7、抗精神病药89、部分第一代抗组胺药10,以及某些迷幻剂,如LSA或2C-C。然而,值得注意的是,少数能在不伴随多种其他效应的情况下选择性诱导这种效应的化合物被称为“催眠药”。

参考文献

参见

外部链接

  1. 嗜睡(维基百科)

引用

  1. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.), 829. Arlington, VA: American Psychiatric Publishing.
  2. Guilleminault, C., & Brooks, S. N. (2001). Excessive daytime sleepiness: a challenge for the practising neurologist. Brain, 124(8), 1482-1491.
  3. Bereshpolova, Y., Stoelzel, C. R., Zhuang, J., Amitai, Y., Alonso, J. M., & Swadlow, H. A. (2011). Getting drowsy? Alert/nonalert transitions and visual thalamocortical network dynamics. Journal of Neuroscience, 31(48), 17480-17487.
  4. Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., ... & Collet, J. P. (2010). Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. Canadian Medical Association Journal, 182(14), E694-E701.
  5. Landauer, A. A., & Howat, P. (1983). Low and moderate alcohol doses, psychomotor performance and perceived drowsiness. Ergonomics, 26(7), 647-657.
  6. Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983). Current status of benzodiazepines. New England Journal of Medicine, 309(7), 410-416.
  7. Corey, P. J., Heck, A. M., & Weathermon, R. A. (1999). Amphetamines to counteract opioid-induced sedation. Annals of Pharmacotherapy, 33(12), 1362-1366.
  8. Van Putten, T., May, P. R., Marder, S. R., & Wittmann, L. A. (1981). Subjective response to antipsychotic drugs. Archives of General Psychiatry, 38(2), 187-190.
  9. Artaloytia, J. F., Arango, C., Lahti, A., Sanz, J., Pascual, A., Cubero, P., ... & Palomo, T. (2006). Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. American Journal of Psychiatry, 163(3), 488-493.
  10. Weiler, J. M., Bloomfield, J. R., Woodworth, G. G., Grant, A. R., Layton, T. A., Brown, T. L., ... & Watson, G. S. (2000). Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator. Annals of Internal Medicine, 132(5), 354-363.
贡献者:Josie·Kaylee·Graham